BiotechSwings
27% Friday and $FLGT actually earned it imo
Q3 revenue hit 90.4 million, up 8% year over year, and the loss came in at 9 cents vs 65 cents expected
pathology did the heavy lifting, up 57% to 40.9 million, and the stock closed at 23.74
they tightened the full year loss guide to 1.65 to 1.75 from 2.22 to 2.35, year end cash guided near 630 million
1
2

:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault32.jpg)
:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault17.jpg)